Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks

The burden of multiple sclerosis (MS) in women of childbearing potential is increasing, with peak incidence around the age of 30 years, increasing incidence and prevalence, and growing female : male ratio. Guidelines recommend early use of disease-modifying therapies (DMTs), which are contraindicate...

Descripción completa

Detalles Bibliográficos
Autores principales: Alroughani, Raed, Altintas, Ayse, Al Jumah, Mohammed, Sahraian, Mohammadali, Alsharoqi, Issa, AlTahan, Abdurahman, Daif, Abdulkader, Dahdaleh, Maurice, Deleu, Dirk, Fernandez, Oscar, Grigoriadis, Nikolaos, Inshasi, Jihad, Karabudak, Rana, Taha, Karim, Totolyan, Natalia, Yamout, Bassem I., Zakaria, Magd, Bohlega, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203912/
https://www.ncbi.nlm.nih.gov/pubmed/28078140
http://dx.doi.org/10.1155/2016/1034912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203912/
https://www.ncbi.nlm.nih.gov/pubmed/28078140
http://dx.doi.org/10.1155/2016/1034912

Ejemplares similares